$DXC

DXC Q2 FY27 slides show earnings beat, but guidance cut sparks selloff

DXC Technology (NYSE:DXC) reported Q2 FY27 earnings beating estimates with $0.67 EPS and $3.03B revenue, but shares fell 17% after-hours due to weak bookings, lower guidance, and a 10% drop in total bookings. The company cut its full-year outlook, citing deal timing and conversion challenges. Despite AI and modernization efforts, organic revenue declined 4.0% YoY, and margins shrank. DXC generated $91M in free cash flow but reduced its FY27 EPS guidance to $2.25-$2.50.

Original reporting
Published Oct 29, 2026, 10:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DXC
Bearish
high confidence
Mentioned
$DXC
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DXCBearishHigh
01

Why it matters

The market reaction is driven by weaker bookings (book-to-bill below 1), regional weakness (Americas, UKI), and a reduced FY27 outlook, which changes forward expectations more than the beat changes backward-looking performance.

02

Market read

This is a same-day earnings-and-guidance reset for DXC, with after-hours selling tied to bookings and FY27 outlook reductions.

03

What to watch

The article notes a one-time insurance contract modification benefiting the quarter and frames deferred deals as timing issues; traders may separate near-term conversion weakness from longer-cycle modernization demand.

Relevance 9/10Novelty 9/10Timing: after-hours reaction to Q2 FY27 results and same-day FY27 guidance cut

Background

DXC reported Q2 FY27 results on Oct 29, 2026, showing an earnings and revenue beat alongside transformation-related execution and demand concerns.

Company-level read

Ticker impact

$DXCBearishHigh confidence
Context

DXC beat Q2 EPS and revenue but cut full-year guidance after-hours, citing weaker bookings, lower book-to-bill, and conversion issues.

Expected impact

Likely further pressure as the market reprices FY27 earnings power around the reduced organic revenue, EBIT margin, and EPS outlook.

Evidence & confidence

The article attributes the 17%+ after-hours selloff directly to weakened bookings, lower book-to-bill, and reduced full-year guidance despite the beat.

Market effects

Signals continued demand softness and conversion risk in IT services, even when AI modernization narratives support selective wins.

Americas and UKI deal timing and conversion deterioration are highlighted as key drags.

Limited direct global spillover beyond IT services sentiment, but reinforces cautious read-through on enterprise IT spending.

Counterpoint

The EPS and revenue beat, plus AI platform utilization gains and an insurance segment growth rebound, could mean the guidance cut is more timing-related than structural for parts of the business.

Key entities

  • DXC Technology Company

    IT services provider that reported Q2 FY27 results and cut full-year guidance due to weaker bookings and conversion.

  • Raul Fernandez

    CEO who attributed some weakness to sales execution and emphasized AI modernization bench-building.

  • Rob Del Bene

    CFO who characterized deferred deals as primarily timing issues while acknowledging Americas project weakness.

  • Anthropic

    AI partner whose Claude platform DXC certified professionals on as commercialization is the next step.

Related articles

$DXCMedAI 8/10

DXC Technology earnings beat by $0.12, revenue topped estimates

DXC Technology (NYSE: DXC) reported Q2 EPS of $0.67, beating estimates by $0.12, with revenue at $3.03B, surpassing expectations. The company guided Q3 2027 EPS at $0.55, below consensus, and revenue at $2.98B, also below estimates. For FY 2027, DXC expects EPS of $2.25-$2.50 and revenue of $11.91B-$11.98B, both under analyst forecasts. The stock is up 35.50% over 3 months and 17.70% over 12 months.

$DXCHighAI 8/10

DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DXC Technology Reports Second Quarter Fiscal Year 2027 Results • Total revenue for Q2 FY27 of $3.03 billion, down 4.0% YoY, down 4.0% on an organic basis (1) • Q2 FY27 EBIT margin of 2.2%, and adjusted EBIT (2) margin of 6.2% • Q2 FY27 Diluted earnings per share of $

$DXCHighAI 8/10

DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology reported Q2 FY27 revenue of $3.03B, down 4% YoY. EBIT margin was 2.2%, and adjusted EBIT margin was 6.2%. EPS was $0.15, with non-GAAP EPS at $0.67, down 20.2% YoY. Free cash flow for H1 FY27 was $405M. Bookings were $2.4B, with a 1.0x book-to-bill ratio. The company repurchased $60M in shares and is discussing a possible sale of its insurance business. Guidance for FY27 includes revenue of $11.91B-$11.98B and non-GAAP EPS of $2.25-$2.50.

$DXCHighAI 9/10

Total revenue fell 4% year over year; DXC expects organic revenue to drop about 6% next quarter from a year earlier.

DXC Technology reported Q2 FY27 revenue of $7.45 billion, down 4% YoY, with adjusted EBIT margin of 6.2% and non-GAAP EPS of $0.15. The company expects Q3 organic revenue to drop 6% YoY. CEO Raul Fernandez highlighted progress in AI-based solutions. DXC also announced potential sale of its insurance business. Full-year revenue is projected to decline 5-5.5% YoY. (299 characters)

$DXCMedAI 8/10

DXC earnings ahead amid $2.4 billion insurance unit sale talks

DXC Technology reports Q2 earnings with analysts expecting EPS of $0.55 and revenue of $2.98B, down YoY but up sequentially. The company is in talks to sell its insurance unit for $2.4B. Analysts have a neutral consensus with a $11.21 price target, implying 30% downside. Investors focus on the sale's impact and DXC's core business stability.